Quetiapine and Wolff-Parkinson-White Syndrome.
Publication/Presentation Date
1-1-2020
Abstract
Quetiapine is occasionally associated with cardiovascular adverse effects such as QTc prolongation. QTc prolongation is a side effect that requires monitoring in order to avoid more serious cardiac complications. One particular understudied area is the potential for antipsychotics to elicit electroconduction abnormalities in patients with Wolff-Parkinson-White (WPW) Syndrome. In the present report, we describe a case of quetiapine overdose in a patient with WPW.
Volume
2020
First Page
6633385
Last Page
6633385
ISSN
2090-682X
Published In/Presented At
Chen, M., Gomaa, H., Cortez-Resendiz, A., Martin, C., Francis, A., & Bellon, A. (2020). Quetiapine and Wolff-Parkinson-White Syndrome. Case reports in psychiatry, 2020, 6633385. https://doi.org/10.1155/2020/6633385
Disciplines
Psychiatry
PubMedID
33381342
Department(s)
Department of Psychiatry
Document Type
Article